Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4688776011 | Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4688777019 | Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Is a | Dexrabeprazole and domperidone only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Gastro-resistant and prolonged-release oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Dexrabeprazole sodium | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Dexrabeprazole sodium | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Domperidone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Domperidone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR